commercialization of vaccines. The company develops its vaccines based on its proprietary
technologies, including the plant-based Proficia technology and Virus-Like Particles (VLP) technology.
Its product candidate includes H5N1 pandemic influenza VLP vaccine, which has completed a Phase I
human clinical trial. The company is also developing H1N1 VLP vaccine for Influenza A/Calif... read more
Specialties and Expertise:Influenza Vaccines Development, Protein-based Therapeutics, Plant-based Proficia Technology, Virus-Like
Particles (VLP) Technology, Influenza VLP Vaccine, Monoclonal Antibody Production, Antibody Glycoengineering, Pandemic Flu... read more
Size and Minority Status
- Products and services 1
- Сommodity codes 4
producing virus-like particles (VLPs) and therapeutic proteins.
Medicago's plant-based Proficia technology uses transient protein expression in plant leaves for producing virus-like particles (VLPs) and therapeutic proteins.
Medicago’s platform can produce both vaccine and antibody candidates against COVID-19 disease. Medicago is using its technology platform to develop antibodies against SARS-CoV-2 in collaboration with Laval University’s Infectious Disease Research Centre. Medicago successfully produced a Virus-Like Particle (VLP) of the coronavirus just 20 days after obtaining the SARS-CoV-2 (virus causing the COVID-19 disease) gene. Production of the VLP is the first step in developing a vaccine for COVID-19 whi read more
Medicago has received a task order from the Biomedical Advanced Research and Development Authority (BARDA) at the U.S. Department of Health and Human Services (HHS) for three anti-Ebola virus monoclonal antibodies (mAbs) with expected performance comparable to that of ZMapp™, from Mapp Biopharmaceutical. Medicago successfully completed the contract with the U.S. government (BARDA) to produce anti-Ebola antibodies.
Biomedical Advanced Research and
Development Authority (BARDA) at the U.S. De...
and antibody candidates against COVID-19
disease. Medicago is using its technology plat...
External Recognition 1
Locations Served 2
Public Spend Forum compiles the information shown in GovShop's supplier profiles based on multiple sources and relies on GovShop's supplier and buyer user community to help validate the information. We recommend conducting further due diligence and research to validate the information if accuracy is critical.